Food News and Research

RSS

1 in 5 Australians have taken an expired medicine

NPS is urging all Australians to clean out their medicine cabinets today as part of national Be Medicinewise Week 2012. New research from NPS found around 1 in 5 people reported ever having taken an expired medicine.

26 Mar 2012

EMA accepts Arena's lorcaserin MAA for weight control

Arena Pharmaceuticals, Inc. announced today that the European Medicines Agency (EMA) has accepted the filing of a Marketing Authorization Application (MAA) for lorcaserin, an investigational drug candidate intended for weight control, including weight loss and maintenance of weight loss, in patients who are obese (BMI >30) or patients who are overweight (BMI >27) and have at least one weight-related co-morbid condition.

26 Mar 2012

FDA approves Teva's QNASL nasal aerosol corticosteroid

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has approved QNASL Nasal Aerosol, a new, "dry" nasal aerosol corticosteroid that treats seasonal nasal and year-round nasal allergy symptoms in adults and adolescents 12 years of age and older.

26 Mar 2012

Accuray releases PlanTouch integrated software application in radiation oncology

Accuray Incorporated, the premier radiation oncology company, announced today the release of PlanTouch, the first commercially available, fully integrated software application in radiation oncology that allows physicians to remotely review and approve patients' radiation treatment plans on the iPad.

26 Mar 2012

AstraZeneca's lawsuit against FDA dismissed without prejudice

AstraZeneca today announced that on March 23, 2012 the US District Court for the District of Columbia issued an opinion and order in AstraZeneca's lawsuit against the US Food and Drug Administration regarding final marketing approval of generic quetiapine. The Court denied the Company's request for a preliminary injunction and dismissed the lawsuit without prejudice.

26 Mar 2012

OSI Systems receives FDA clearance for Arkon anesthesia delivery system

OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, received clearance under Section 510(k) from the U.S. Food and Drug Administration to market the Arkon high-performance anesthesia delivery system.

26 Mar 2012

Nordion introduces new custom dose feature in Canada, Europe for TheraSphere

Nordion Inc., a leading provider of products and services for the prevention, diagnosis and treatment of disease, today launched a new custom dose feature in Europe and Canada for TheraSphere, Nordion's Y-90 microsphere treatment for liver cancer.

26 Mar 2012

Panasonic launches new CardioHealth Station software

Panasonic Healthcare Group today debuted new, enhanced software for the CardioHealth Station at the American College of Cardiology's (ACC's) 61st Annual Scientific Session & Expo, ACC.12, being held March 24 though March 28 in Chicago.

From PHC Europe B.V. 26 Mar 2012

Medtronic announces results from two Symplicity system trials on treatment-resistant hypertension

Medtronic, Inc., announced that the Symplicity renal denervation system provides safe, significant and sustained blood pressure reduction up to three years in patients with treatment-resistant hypertension, according to data from two clinical trials presented at the 2012 American College of Cardiology (ACC) meeting.

From Medtronic 26 Mar 2012

Medgenics to commence EPODURE Biopumps Phase IIa study in ESRD-related anemia

Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced receipt of clearance from the Israeli Ministry of Health to initiate a Phase IIa clinical study evaluating the safety and efficacy of sustained erythropoietin therapy produced and delivered by the Company's EPODURE Biopumps.

26 Mar 2012

FDA Advisory Committee to review Repligen's SecreFlo NDA on May 31

Repligen Corporation today announced that the U.S. Food and Drug Administration's Gastrointestinal Drugs Advisory Committee will meet on May 31, 2012 to discuss the Company's New Drug Application (NDA) for SecreFlo for the improved detection of pancreatic duct abnormalities in combination with magnetic resonance imaging (MRI) in patients with pancreatitis.

26 Mar 2012

57% of Australians make mistakes with their medicines

New research from NPS has found that 57% of Australians report they have made a mistake with their medicines in the past 12 months.

25 Mar 2012

Dissolvable tobacco harmless finds FDA panel but promises detailed review

An advisory panel to the Food and Drugs Administration (FDA) said Thursday that people who exclusively use dissolvable tobacco products have a greatly reduced risk of cancer and respiratory illness compared with those who regularly smoke cigarettes.

25 Mar 2012

More supermarkets shun “pink slime”

Supermarket chains Kroger Co. and Stop & Shop announced Thursday that they would no longer sell beef that includes an additive with the unappetizing “pink slime.” Federal regulators say the ammonia-treated filler, known in the industry as “lean, finely textured beef,” meets food safety standards. But critics say the product could be unsafe and is an unappetizing example of industrialized food production.

25 Mar 2012

Ibuprofen may be used effectively for altitude sickness: Study

Altitude sickness manifests by symptoms including a headache, fatigue, dizziness and sometimes nausea and vomiting. In addition, patients most likely also feel like they are working harder to breathe, like they are constantly trying to catch their breath. It normally takes days to weeks to fully acclimate to a higher altitude. It affects between 25 percent and 40 percent of the population and can be debilitating.

25 Mar 2012

Sixty-thousand Canadian teens go hungry to raise money and hunger awareness

As Canadians flock to movie theatres across the country for the much-anticipated Hunger Games motion picture release this weekend, more than 60,000 teens are preparing to go hungry to raise money and hunger awareness as part of World Vision's 30 Hour Famine, the largest teen hunger awareness campaign in the world.

23 Mar 2012

'The Hunger Games' film could raise awareness about hunger

In this post in State Department's "DipNote" blog, Paul Weisenfeld, assistant to the administrator of the USAID Bureau of Food Security, writes of the new film "The Hunger Games," "I was struck by how much the premise relates to the very heart of what we are trying to address at USAID and through Feed the Future."

23 Mar 2012

Efforts must continue to bring clean water, sanitation, food to the world

In a post on Science Blogs' "The Pump Handle," Liz Borkowski, a research associate at the George Washington University School of Public Health's Department of Environmental and Occupational Health, recognizes World Water Day, discusses the importance of access to clean water and sanitation facilities.

23 Mar 2012

FDA clears multiple enhancements to St. Jude Medical's FFR measurement guidewire

St. Jude Medical, Inc., a global medical device company, today announced it has received U.S. Food and Drug Administration (FDA) clearance for multiple enhancements to its PressureWire Fractional Flow Reserve (FFR) measurement guidewire.

23 Mar 2012

Treatment with aromatase inhibitors enables some women to have lumpectomy

Preoperative treatment with aromatase inhibitors increases the likelihood that postmenopausal women with estrogen receptor-positive breast cancer will be able to have breast-conserving surgery rather than a mastectomy, according to the results of a national clinical trial presented today at the Society of Surgical Oncology annual meeting in Orlando, Fla.

23 Mar 2012